Open Access
Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India
Cureus · 22.04.2026
DOI: 10.7759/cureus.107542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 22.04.2026. Verfasst von Atanu Pal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology, ILS Hospital, Kolkata, IND. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
chronic kidney diseasedapaglifloziniga nephropathynon-diabetic ckdproteinuriasglt2 inhibitors
Autor:innen und Institutionen
- Rheumatology, ILS Hospital, Kolkata, IND.
- Nephrology, Institute of Post Graduate Medical Education & Research, Kolkata, IND.
Zitieren
APA
Pal, A., & Sadhukhan, S. (2026). Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India. Cureus. https://doi.org/10.7759/cureus.107542
Vancouver
Pal A, Sadhukhan S. Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India. Cureus. 2026. doi:10.7759/cureus.107542
BibTeX
@article{Pal2026,
author = {Pal, Atanu and Sadhukhan, Sourav},
title = {Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.107542}
}
EUVIMED